PL1963292T3 - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- PL1963292T3 PL1963292T3 PL06839094T PL06839094T PL1963292T3 PL 1963292 T3 PL1963292 T3 PL 1963292T3 PL 06839094 T PL06839094 T PL 06839094T PL 06839094 T PL06839094 T PL 06839094T PL 1963292 T3 PL1963292 T3 PL 1963292T3
- Authority
- PL
- Poland
- Prior art keywords
- organic compounds
- compounds
- organic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74857305P | 2005-12-08 | 2005-12-08 | |
EP06839094A EP1963292B1 (en) | 2005-12-08 | 2006-12-06 | Organic compounds |
PCT/US2006/046545 WO2007067615A2 (en) | 2005-12-08 | 2006-12-06 | Thiadiazole derivatives as antidiabetic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1963292T3 true PL1963292T3 (en) | 2012-07-31 |
Family
ID=37950917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06839094T PL1963292T3 (en) | 2005-12-08 | 2006-12-06 | Organic compounds |
Country Status (26)
Country | Link |
---|---|
US (1) | US7700633B2 (en) |
EP (1) | EP1963292B1 (en) |
JP (1) | JP2009519248A (en) |
KR (1) | KR20080074969A (en) |
CN (1) | CN101326173A (en) |
AR (1) | AR056838A1 (en) |
AT (1) | ATE546440T1 (en) |
AU (1) | AU2006321905B2 (en) |
BR (1) | BRPI0619600A2 (en) |
CA (1) | CA2629857A1 (en) |
CR (1) | CR10049A (en) |
EC (1) | ECSP088506A (en) |
ES (1) | ES2381280T3 (en) |
IL (1) | IL191549A0 (en) |
MA (1) | MA30202B1 (en) |
NO (1) | NO20083031L (en) |
NZ (1) | NZ568243A (en) |
PE (2) | PE20100733A1 (en) |
PL (1) | PL1963292T3 (en) |
PT (1) | PT1963292E (en) |
RU (1) | RU2008127254A (en) |
TN (1) | TNSN08249A1 (en) |
TW (1) | TW200732315A (en) |
UA (1) | UA94724C2 (en) |
WO (1) | WO2007067615A2 (en) |
ZA (1) | ZA200804074B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA94921C2 (en) | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
RU2008127253A (en) * | 2005-12-08 | 2010-01-20 | Новартис АГ (CH) | 1,1,3-TRIOXO-1,2,5-THIADIAZOLIDINES AND THEIR APPLICATION AS PTFASE INHIBITORS |
JP2009518420A (en) * | 2005-12-08 | 2009-05-07 | ノバルティス アクチエンゲゼルシャフト | 1,2,5-thiazolidine derivatives useful for the treatment of conditions mediated by protein tyrosine phosphatases (PTPASE) |
WO2008067527A1 (en) * | 2006-12-01 | 2008-06-05 | Novartis Ag | Inhibitors of protein tyrosine phosphatase for the treatment of muscle atrophy and related disorders |
AR066820A1 (en) * | 2007-06-04 | 2009-09-16 | Novartis Ag | TIADIAZOLIDIN-3 ONA COMPOUNDS |
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
AU2011313191A1 (en) | 2010-10-08 | 2013-05-02 | Mochida Pharmaceutical Co., Ltd. | Cyclic amide derivative |
JPWO2012147516A1 (en) | 2011-04-28 | 2014-07-28 | 持田製薬株式会社 | Cyclic amide derivative |
BR112021012311A2 (en) * | 2018-12-21 | 2021-09-08 | Crystal Pharma, S.A.U. | USE OF AN INTERMEDIATE COMPOUND, PROCESS TO PREPARE VOXELOTOR AND INTERMEDIATE COMPOUND |
KR102533599B1 (en) * | 2019-03-14 | 2023-05-17 | 칼리코 라이프 사이언시스 엘엘씨 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
GB201915094D0 (en) * | 2019-10-18 | 2019-12-04 | Balticgruppen Bio Ab | New formulations |
JP2023508914A (en) * | 2019-12-20 | 2023-03-06 | カリコ ライフ サイエンシーズ エルエルシー | Protein tyrosine phosphatase degrading agent and method of using the same |
JP2024509962A (en) * | 2021-03-11 | 2024-03-05 | カムクワット バイオサイエンシーズ インコーポレイテッド | Heterocycles and their uses |
WO2023086498A1 (en) * | 2021-11-11 | 2023-05-19 | Calico Life Sciences Llc | Protein tyrosine phosphatase inhibitors and methods of use thereof |
TW202337459A (en) * | 2022-02-02 | 2023-10-01 | 美商耐瑞歐醫療公司 | Protein tyrosine phosphatase inhibitors and uses thereof |
WO2023150150A1 (en) * | 2022-02-02 | 2023-08-10 | Nerio Therapeutics, Inc. | Protein tyrosine phosphatase inhibitors and uses thereof |
AU2023216239A1 (en) * | 2022-02-02 | 2024-08-08 | Nerio Therapeutics, Inc. | Protein tyrosine phosphatase inhibitors and uses thereof |
WO2024059041A1 (en) * | 2022-09-13 | 2024-03-21 | Kumquat Biosciences, Inc. | Benzo-fused n-heterocycles and uses thereof |
WO2024067802A1 (en) * | 2022-09-30 | 2024-04-04 | 深圳众格生物科技有限公司 | Protein tyrosine phosphatase inhibitor, preparation method therefor, and pharmaceutical use thereof |
WO2024141015A1 (en) * | 2022-12-30 | 2024-07-04 | Insilico Medicine Ip Limited | Protein tyrosine phosphatase inhibitors and uses thereof |
CN117343052B (en) * | 2023-12-04 | 2024-02-06 | 英矽智能科技(上海)有限公司 | Protein tyrosine phosphatase inhibitors and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2349589C2 (en) * | 2002-04-03 | 2009-03-20 | Новартис Аг | 5-SUBSTITUTED DERIVATIVES OF 1,1-DIOXO-1,2,5-THIAZOLIDIN-3-ONE AS PTPase 1B INHIBITORS |
GB0225986D0 (en) * | 2002-11-07 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
GB0227813D0 (en) * | 2002-11-29 | 2003-01-08 | Astrazeneca Ab | Chemical compounds |
ATE432074T1 (en) * | 2002-12-30 | 2009-06-15 | Vertex Pharma | SULFHYDANTOINS AS PHOSPHATISOSTERES FOR USE AS PHOSPHATASE INHIBITORS IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES |
WO2005035551A2 (en) * | 2003-10-08 | 2005-04-21 | Incyte Corporation | Inhibitors of proteins that bind phosphorylated molecules |
RU2008127253A (en) * | 2005-12-08 | 2010-01-20 | Новартис АГ (CH) | 1,1,3-TRIOXO-1,2,5-THIADIAZOLIDINES AND THEIR APPLICATION AS PTFASE INHIBITORS |
JP2009518420A (en) * | 2005-12-08 | 2009-05-07 | ノバルティス アクチエンゲゼルシャフト | 1,2,5-thiazolidine derivatives useful for the treatment of conditions mediated by protein tyrosine phosphatases (PTPASE) |
AU2007233251A1 (en) * | 2006-03-31 | 2007-10-11 | Novartis Ag | Thiadiazolidinone inhibitors of PTPase |
-
2006
- 2006-06-12 UA UAA200807751A patent/UA94724C2/en unknown
- 2006-12-06 AR ARP060105392A patent/AR056838A1/en not_active Application Discontinuation
- 2006-12-06 WO PCT/US2006/046545 patent/WO2007067615A2/en active Application Filing
- 2006-12-06 PE PE2010000531A patent/PE20100733A1/en not_active Application Discontinuation
- 2006-12-06 NZ NZ568243A patent/NZ568243A/en not_active IP Right Cessation
- 2006-12-06 BR BRPI0619600-4A patent/BRPI0619600A2/en not_active IP Right Cessation
- 2006-12-06 AU AU2006321905A patent/AU2006321905B2/en not_active Ceased
- 2006-12-06 CN CNA2006800461637A patent/CN101326173A/en active Pending
- 2006-12-06 PE PE2006001571A patent/PE20071031A1/en not_active Application Discontinuation
- 2006-12-06 RU RU2008127254/04A patent/RU2008127254A/en not_active Application Discontinuation
- 2006-12-06 US US12/096,439 patent/US7700633B2/en not_active Expired - Fee Related
- 2006-12-06 PL PL06839094T patent/PL1963292T3/en unknown
- 2006-12-06 AT AT06839094T patent/ATE546440T1/en active
- 2006-12-06 PT PT06839094T patent/PT1963292E/en unknown
- 2006-12-06 JP JP2008544467A patent/JP2009519248A/en active Pending
- 2006-12-06 ES ES06839094T patent/ES2381280T3/en active Active
- 2006-12-06 KR KR1020087013716A patent/KR20080074969A/en not_active Application Discontinuation
- 2006-12-06 EP EP06839094A patent/EP1963292B1/en active Active
- 2006-12-06 CA CA002629857A patent/CA2629857A1/en not_active Abandoned
- 2006-12-07 TW TW095145713A patent/TW200732315A/en unknown
-
2008
- 2008-05-13 ZA ZA200804074A patent/ZA200804074B/en unknown
- 2008-05-19 IL IL191549A patent/IL191549A0/en unknown
- 2008-06-02 MA MA30987A patent/MA30202B1/en unknown
- 2008-06-05 CR CR10049A patent/CR10049A/en not_active Application Discontinuation
- 2008-06-06 EC EC2008008506A patent/ECSP088506A/en unknown
- 2008-06-06 TN TNP2008000249A patent/TNSN08249A1/en unknown
- 2008-07-04 NO NO20083031A patent/NO20083031L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2006321905B2 (en) | 2011-08-11 |
US7700633B2 (en) | 2010-04-20 |
KR20080074969A (en) | 2008-08-13 |
US20080262050A1 (en) | 2008-10-23 |
PE20071031A1 (en) | 2007-11-15 |
WO2007067615A3 (en) | 2007-11-15 |
TNSN08249A1 (en) | 2009-10-30 |
UA94724C2 (en) | 2011-06-10 |
CN101326173A (en) | 2008-12-17 |
EP1963292A2 (en) | 2008-09-03 |
EP1963292B1 (en) | 2012-02-22 |
ES2381280T3 (en) | 2012-05-24 |
MA30202B1 (en) | 2009-02-02 |
WO2007067615A2 (en) | 2007-06-14 |
ZA200804074B (en) | 2009-03-25 |
PE20100733A1 (en) | 2010-10-29 |
NZ568243A (en) | 2011-07-29 |
PT1963292E (en) | 2012-05-10 |
AR056838A1 (en) | 2007-10-24 |
CR10049A (en) | 2008-08-25 |
JP2009519248A (en) | 2009-05-14 |
ECSP088506A (en) | 2008-07-30 |
RU2008127254A (en) | 2010-01-20 |
NO20083031L (en) | 2008-08-28 |
AU2006321905A1 (en) | 2007-06-14 |
CA2629857A1 (en) | 2007-06-14 |
IL191549A0 (en) | 2008-12-29 |
TW200732315A (en) | 2007-09-01 |
ATE546440T1 (en) | 2012-03-15 |
BRPI0619600A2 (en) | 2011-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0510390D0 (en) | Organic compounds | |
EP1888534A4 (en) | Organic compounds | |
GB0507575D0 (en) | Organic compounds | |
GB0500435D0 (en) | Organic compounds | |
GB0500785D0 (en) | Organic compounds | |
GB0508319D0 (en) | Organic compounds | |
GB0505969D0 (en) | Organic compounds | |
PL1963292T3 (en) | Organic compounds | |
GB0502358D0 (en) | Organic compounds | |
GB0507577D0 (en) | Organic compounds | |
GB0503646D0 (en) | Organic compounds | |
GB0507696D0 (en) | Organic compounds | |
GB0507298D0 (en) | Organic compounds | |
GB0504850D0 (en) | Organic compounds | |
GB0505219D0 (en) | Organic compounds | |
GB0504194D0 (en) | Organic compounds | |
GB0510810D0 (en) | Organic compounds | |
GB0504544D0 (en) | Organic compounds | |
GB0508992D0 (en) | Organic compounds | |
GB0511060D0 (en) | Organic compounds | |
GB0501237D0 (en) | Organic compounds | |
GB0500784D0 (en) | Organic compounds | |
GB0504203D0 (en) | Organic compounds | |
GB0500683D0 (en) | Organic compounds | |
GB0507695D0 (en) | Organic compounds |